As the global pharmaceutical industry navigates the dynamic landscape of clinical research, China has firmly established its dominance in trial…
Read More
Global Healthcare Giants Unite: GHO Capital and CBC Group Forge Largest Dedicated Investment Manager with $21 Billion AUM
Two prominent forces in specialized healthcare investment, Global Healthcare Opportunities (GHO) and CBC Group, have announced a groundbreaking merger to…
Read More
The Evolving Landscape of Ovarian Cancer Research: Navigating Complexity and Embracing Global Strategies
The field of ovarian cancer research is undergoing a profound transformation, driven by significant advancements in personalized medicine and innovative…
Read More
Sai Life Sciences’ Biotech Pitch Day 2026 Unveils Groundbreaking Innovations from Early-Stage Biotechs, Reinforcing Global Drug Discovery Ecosystem
Sai Life Sciences, a leading global contract research, development, and manufacturing organization (CRDMO), recently convened its highly anticipated Biotech Pitch…
Read More
Scientists Pioneer World’s First Human Antibody Treatment for Measles, Offering Critical Defense Amid Global Resurgence
In a groundbreaking development that promises to reshape the global fight against measles, scientists at the La Jolla Institute for…
Read More
ACROBiosystems Enhances Global Licensing for HEK293 Functional Cell Lines to Accelerate Biopharmaceutical R&D
ACROBiosystems has announced a significant upgrade to its global licensing solution for HEK293 functional cell lines, a move poised to…
Read More
Solar Powered Plastic Transformation Offers Dual Solution to Global Pollution and Energy Demands
A pioneering research initiative led by the University of Adelaide is charting a new course for the global energy transition…
Read More
Chinese Biotechs Emerge as Global Pharma Powerhouses, Securing One-Third of Major Deal Value in 16 Months
Over the past sixteen months, Chinese-domiciled biotechnology companies have solidified their position as pivotal players in the global pharmaceutical landscape,…
Read More
Madrigal Pharmaceuticals Secures Global Rights to Arrowhead’s siRNA Asset for MASH, Paving Way for Combination Therapy Exploration
Madrigal Pharmaceuticals has significantly bolstered its pipeline for metabolic dysfunction-associated steatohepatitis (MASH) by acquiring the global rights to Arrowhead Pharmaceuticals’…
Read More
Turning Plastic Waste into Clean Energy The Global Shift Toward Solar Powered Chemical Upcycling
In an era defined by the dual crises of mounting environmental degradation and an urgent need for sustainable energy, a…
Read More
